Alimta

earns view for Q4 by penny - Pharmaceuticals - Earnings Member ID: Password: Free membershipSpecial offersHelp FRONT PAGEMARKETSGLOBAL MARKETSIPOsECONOMY & POLITICSFUNDS/ETFsCOMMENTARYSPECIAL REPORTS ENTER SYMBOL(S) Quote/NewsChartsProfileAdvisersAnalystsInsidersOptionsFinancialsMessagesSEC FilingFind symbolLive quotesKeyword searchFree Investors Secrets Book BECOME A MEMBER Special Offers!

My Portfolios My Alerts e-Newsletters Discussions View all member benefits FREE!

SPONSORED LINKS eSignal - Know More, Make More Get on top of the latest stock developments with eSignal software.

With live data, mobile quotes and charts, educational tools, and more, we strive keep you in the know.

Free 30-day trial.

Introducing $7 Limit Orders at Scottrade Now at Scottrade, not only are market orders $7, but limit orders are too.

Only $500 to open an account.

There are no inactive account fees or account maintenance fees.

Apply online.

WSJ.COM HIGHLIGHTSAvailable free to MarketWatch readers: Getting out As REIT shares hit highs, executives make a flurry of insider sales.

For WSJ.com subscribers: Long and short Many knew it at the time; now everyone does: Walter Hewlett was right about avoiding Compaq.

What’s your workout?

How an Accenture consultant uses cycling for relaxation and fitness - and the occasional 24-hour endurance test.

TOP FEATURES Trading Strategies EarningsWatch Weekly earnings calendar Market Snapshot Movers & Shakers Silicon Sto...

Read more...